Providence Therapeutics
PrivateLast Round
Grant
Dec 7, 2021
Total Funding Raised
$9.62M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Providence Therapeutics is a biotechnology company that develops messenger RNA (mRNA) medicines for cancer treatment and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Providence Therapeutics Comparables
Compare Providence Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PopVax | 85% | |
| Stemirna Therapeutics | 79% | |
| Abogen Biosciences | 79% | |
Providence Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 7, 2021 | ||||
| Grant | Jan 21, 2021 | ||||
| Grant | Oct 1, 2020 |
Key People
Founding team and executive leadership
Providence Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Research Council Canada Industrial Research Assistance Program | Grant |
| Bill & Melinda Gates Foundation | Grant |
| Next Generation Manufacturing Canada (NGen) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Open roles increased to 13, 5.6x the trailing average.
- Aug 23, 2025
Grew 17% QoQ, from 53 to 62 employees.
Providence Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Providence Therapeutics's valuation, stock price, and market status.